Out-of-Pocket Expenses in Households of People Living with Obesity in France

Archive ouverte

Fabron, Cécile | Laville, Martine | Aron-Wisnewsky, Judith | Disse, Emmanuel | Gatta-Cherifi, Blandine | Jacobi, David | Montastier, Emilie | Oppert, Jean-Michel | Gaillard, Léa | Detournay, Bruno | Czernichow, Sébastien

Edité par CCSD ; Karger AG -

International audience. Background/Objectives: Overweight and obesity result in a substantial economic burden in both low- and high-income countries. Moreover, this burden is often underestimated because it only partially accounts for unreimbursed out-of-pocket expenses (OOPE) related to obesity. The objective of our study was not only to evaluate OOPE incurred by people with obesity in relation to their disease with respect to direct medical expenditures and direct non-medical expenditures but also the proportion of people living with obesity who have forgone obesity-related healthcare due to the costs of such care. Methods: An observational descriptive survey was conducted among people with class II/III obesity attending six obesity treatment centers in France. Volunteer adult participants completed a written/phone questionnaire on their related expenditures over the last 6 months for current expenditures and over the last 5 years for occasional ones. The costs were expressed in 2022 EUR. Results: 299 people participated (age: 46 years [SD: 13.9], women: 72%, BMI ≥40 kg/m2: 62% and 48% with comorbidities). 65% had a professional activity. 83% declared that they had OOPE related to obesity representing annually EUR 2027/individual on average (5% of the household revenue), including weight loss and nutritional products, vitamins, meal programs, gym memberships, psychologists, but mainly adapted clothing, additional travel costs, and others. 15% of the respondents had to modify their professional activity due to obesity and 15% forwent some medical care in the last 12 months. Conclusions: OOPE is a significant part of the economic burden of obesity. Despite some limitations due to the specificities of the participants and because some costs may be more related to social activities affected by obesity than to healthcare, it seems important to consider these expenditures in cost estimates for obesity. © The Author(s) 2023.

Suggestions

Du même auteur

Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data

Archive ouverte | Disse, Emmanuel | CCSD

International audience. Aim:- To describe baseline characteristics and safety data of real-world use of semaglutide 2.4 mg. Methods:- Patients with a body mass index (BMI) >= 40 kg/m2 and at least one of the foll...

A series of severe neurologic complications after bariatric surgery in France: the NEUROBAR Study

Archive ouverte | Alligier, Maud | CCSD

International audience. Background: Neurologic complications after bariatric surgery are rare, but can have dramatic consequences. Little data are available on this topic.Objectives: The aim of the Neurologic compli...

Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement

Archive ouverte | Cuny, Thomas | CCSD

International audience. Craniopharyngiomas are rare hypothalamic-pituitary tumors found in young children, adolescents and adults, and their multidisciplinary management required, calls for consistent practices for ...

Chargement des enrichissements...